DERMATOLOGICALS IN BELGIUM

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Promoting Self-medication Could Be the Solution

OTC Dermatologicals Facing Competition From All Sides

Too Small To Be Profitable

Competitive Landscape

Janssen-cilag Leads But Remains Loyal To Traditional Strategies

Advertising Important Strategy for Antifungals

Similar B2c Strategies for Other Dynamic Players

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018

Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Executive Summary

Differing Fates for OTC Products and Other Consumer Health

Non-otc Products Also Have Their Own Constraints

Generic, Medium-sized And/or Local Manufacturers Fare Better Than Ethical Multinationals

Movement Within Distribution

Manufacturers Remain Wary of Future Legislation

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format and Category: % Value 2018

Table 17 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Definitions

Sources

Summary 2 Research Sources

After another year of decline in 2017, the marginal current value growth of dermatologicals in 2018 could be the sign of an improvement for dermatologicals. Topical antifungals and, in particular, vaginal antifungals often have a semi-ethical and reimbursed profile (theoretically not included in Euromonitor International data), and sales were previously dampened by intense competition from Rx oral equivalent products. However, with patience and advertising support, Bayer managed to develop self-...

Euromonitor International's Dermatologicals in Belgium report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.